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Obesity and consequent type II diabetes are
rising at epidemic rates in the United States
and many other countries around the world,
burdening individual lives and the community
with substantial morbidity and mortality, as
well as attendant ﬁnancial costs. Two of three
U.S. adults are now classified as overweight
(Ogden et al. 2006), contributing to a parallel
increase in the incidence of type II diabetes
(Onkamo et al. 1999; Zimmet et al. 2001).
The potential role of early-life chemical expo-
sures in obesity and diabetes has garnered far
less interest in comparison to factors such as
diet and lifestyle, genetics, race and ethnicity,
and socioeconomic status (Frayling et al.
2007; Stein and Colditz 2004; Wang and
Beydoun 2007), but there is increasing evi-
dence that such exposures may have a signiﬁ-
cant impact. As just one example, it is clear
that maternal smoking during pregnancy pro-
duces metabolic reprogramming that leads to
subsequent risk of obesity in the offspring (Al
Mamun et al. 2006; Chen et al. 2006; Gao
et al. 2005; Power and Jefferis 2002; Toschke
et al. 2003; von Kries et al. 2002). Recent
attention has turned to the organophosphate
pesticides, which represent 50% of all the
insecticide use worldwide (Casida and
Quistad 2004) and to which virtually all
children are exposed (Morgan et al. 2005).
There are epidemiologic links between pesti-
cide exposure and diabetes (Morgan et al.
1980; Saldana et al. 2007), and the same
subpopulations that have the highest rates of
obesity—inner-city, low-socioeconomic-
status, agricultural populations—are also those
that have greater exposure to organophos-
phates and other pesticides (Curl et al. 2002;
Eskenazi et al. 2007; Fenske et al. 2000;
Perera et al. 2005; Petchuay et al. 2006;
Rothlein et al. 2006; Whyatt et al. 2005).
Superimposed on these relationships, children
are exposed more than adults because of their
higher food and water consumption per kilo-
gram body weight and their higher surface-to-
volume ratio (Garry 2004; Landrigan et al.
1999; National Research Council 1993;
Physicians for Social Responsibility 1995;
Whyatt et al. 2007).
Although most studies of organophos-
phates focus on their neurotoxicity, there is
increasing evidence that these agents may also
have a lasting impact on metabolic function.
Animal studies conﬁrm that organophosphate
administration in adults can lead to enhanced
weight gain (Meggs and Brewer 2007) and
diabetes-like changes in hepatic energy
metabolism (Abdollahi et al. 2004). These
relationships may be even more important
when exposure occurs during development.
Fetal and neonatal rats exposed to chlorpyri-
fos showed excess weight gain and leptin dys-
regulation (Lassiter and Brimijoin 2008), in
association with sensitization of hepatic cell
signaling to gluconeogenic and lipolytic
inputs (Meyer et al. 2004), culminating in a
metabolic pattern characteristic of dys-
lipidemia and prediabetes (Slotkin et al.
2005). Neonatal treatment with different
doses of diazinon, straddling the threshold for
significant cholinesterase inhibition, pro-
duced a biphasic effect on metabolism and on
the weight gain evoked by increased dietary
fat intake (Roegge et al. 2008); after low-level
neonatal exposures, diazinon enhanced the
weight gain evoked by a high-fat diet in
adulthood, whereas the interaction was
blunted at higher exposure levels.
The present study focused on yet a third
organophosphate, parathion, which is more
potent toward systemic toxicity than chlor-
pyrifos or diazinon but that at low, subtoxic
doses, also differs from them in many other
aspects of developmental neurotoxicity
(Slotkin et al. 2006a, 2006b, 2007a, 2007b,
2008b). Here, we evaluated the lasting effects
after a brief period of neonatal parathion
treatment straddling the dose threshold for
the first overt signs of toxicity, as character-
ized by a loss of viability of approximately
5–10% (Slotkin et al. 2006a). Evaluations
consisted of longitudinal measures of weight
gain, with assessment of serum markers to
characterize glucose and lipid metabolism. In
addition, we evaluated the effects of switching
the animals to a high-fat diet, looking speciﬁ-
cally for whether early-life parathion exposure
would change the weight gain and/or meta-
bolic responses to increased fat intake.
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BACKGROUND: Developmental exposures to organophosphate pesticides are virtually ubiquitous.
These agents are neurotoxicants, but recent evidence also points to lasting effects on metabolism. 
OBJECTIVES: We administered parathion to neonatal rats. In adulthood, we assessed the impact on
weight gain, food consumption, and glucose and lipid homeostasis, as well as the interaction with
the effects of a high-fat diet.
METHODS: Neonatal rats were given parathion on postnatal days 1–4 using doses (0.1 or
0.2 mg/kg/day) that straddle the threshold for barely detectable cholinesterase inhibition and the
ﬁrst signs of systemic toxicity. In adulthood, animals were either maintained on standard lab chow
or switched to a high-fat diet for 7 weeks.
RESULTS: In male rats on a normal diet, the low-dose parathion exposure caused increased weight
gain but also evoked signs of a prediabetic state, with elevated fasting serum glucose and impaired
fat metabolism. The higher dose of parathion reversed the weight gain and caused further meta-
bolic defects. Females showed greater sensitivity to metabolic disruption, with weight loss at either
parathion dose, and greater imbalances in glucose and lipid metabolism. At 0.1 mg/kg/day
parathion, females showed enhanced weight gain on the high-fat diet; This effect was reversed in
the 0.2-mg/kg/day parathion group, and was accompanied by even greater deﬁcits in glucose and
fat metabolism. 
CONCLUSIONS: Neonatal low-dose parathion exposure disrupts glucose and fat homeostasis in a
persistent and sex-selective manner. Early-life toxicant exposure to organophosphates or other envi-
ronmental chemicals may play a role in the increased incidence of obesity and diabetes.
KEY WORDS: developing rat, diabetes, glucose homeostasis, high-fat diet, insulin, lipid homeostasis,
obesity, organophosphate insecticides, parathion. Environ Health Perspect 116:1456–1462 (2008).
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Animal treatments and diet. All experiments
were carried out humanely and with regard for
alleviation of suffering, following protocols
approved by the Duke University Institutional
Animal Care and Use Committee and in
accordance with all federal and state guide-
lines. Timed-pregnant Sprague–Dawley rats
(Charles River, Raleigh, NC) were housed in
breeding cages, with a 12 hr light–dark cycle
and free access to water and food (LabDiet
5001; PMI Nutrition, St. Louis, MO). On
the day after birth, all pups were randomized
and redistributed to the dams with a litter size
of 10 (5 males, 5 females) to maintain a stan-
dard nutritional status. Parathion (99.2%
purity; Chem Service, West Chester, PA) was
dissolved in dimethylsulfoxide to provide con-
sistent absorption (Slotkin et al. 2006a, 2006b;
Whitney et al. 1995) and was injected sub-
cutaneously in a volume of 1 mL/kg once daily
on postnatal days (PNDs) 1–4; control animals
received equivalent injections of dimethylsul-
foxide vehicle. Doses of 0.1 and 0.2 mg/kg/day
were chosen because they straddle the thresh-
old for barely detectable cholinesterase inhibi-
tion and the ﬁrst signs of reduced weight gain
or impaired viability (Slotkin et al. 2006a,
2006b). Brain cholinesterase inhibition 24 hr
after the last dose of 0.1 mg/kg parathion is
reduced 5–10%, well below the 70% threshold
necessary for symptoms of cholinergic hyper-
stimulation (Clegg and van Gemert 1999).
Randomization of pup litter assignments
within treatment groups was repeated at inter-
vals of several days up until weaning, and dams
were rotated among litters to distribute any
maternal caretaking differences randomly
across litters and treatment groups. Offspring
were weaned on PND21.
For the body weight and serum measure-
ments, there were 12 rats per treatment group
for each sex, with no more than one male and
one female derived from a given litter in each
group. Individual body weights were recorded
weekly; beginning immediately after weaning,
animals were handled every few days to
accustom them to removal from the cage and
contact with investigators. On PND105
(postnatal week 15) and continuing through
the end of the study (PND154; postnatal
week 22), half the rats were switched to a
high-fat diet (OpenSource D12330; Research
Diets Inc., New Brunswick, NJ), providing
58% of total calories as fat; this starting point
for dietary manipulation was chosen so that
we could draw parallels with our earlier work
on diazinon (Roegge et al. 2008). The remain-
ing rats continued on the standard LabDiet
5001 diet, which provides 13.5% of total calo-
ries as fat. Food consumption was recorded
twice weekly. During the 22nd postnatal
week, rats were restrained in a polyfilm
restraint cone (Harvard Apparatus, Holliston,
MA), and blood was sampled by saphenous
venipuncture into serum separator tubes
(capiject T-MG; Terumo, Elkton, MD).
Samples were allowed to clot for 30 min and
were sedimented for collection of serum,
which was then stored at –80°C. A second
whole blood sample was hemolyzed in dis-
tilled water and sodium azide for glycated
hemoglobin (HbA1c) measurement. Food
was then removed from the cage overnight,
and a third sample was obtained with rats in
the fasted state (12–14 hr without food).
Assays. Serum glucose, cholesterol,
β-hydroxybutyrate, nonesterified fatty acids
(NEFA), and triglycerides were determined
with an Olympus Au640 Clinical Chemistry
Analyzer (Olympus America Inc., Melville,
NY). Serum insulin was measured using a
radioimmunoassay kit (Millipore, Billerica,
MA). The hemolyzed blood sample was
assayed for the percentage of HbA1c using a
ColumnMate analyzer (Helena Laboratories,
Beaumont, TX).
Data analysis. Data are presented as
means and SEs. To establish the effects of
parathion and its relationship to the high-fat
diet and other variables, we ﬁrst conducted a
multivariate analysis of variance (ANOVA;
data log-transformed because of hetero-
geneous variance), which encompassed all
variables in a global test in order to avoid
increased type 1 errors that might result from
repeated testing of the data set. The factors
were neonatal treatment, diet, sex, serum
measurement, and feeding status (fed vs.
fasted; repeated measure, because each animal
was evaluated in both states). Data were then
subdivided according to the interactions
between the variables to permit lower-order
ANOVAs; where permitted by the interaction
terms, individual groups that differed from
control were identiﬁed with Fisher’s protected
least significant difference test. Significance
was assumed at the level of p < 0.05. For
interactions at p < 0.1, we also examined
whether lower-order main effects were
detectable after subdivision of the interactive
variables (Snedecor and Cochran 1967). The
criterion for interaction terms was not used to
assign signiﬁcance to the effects but rather to
identify interactive variables requiring sub-
division for lower-order tests of main effects
of parathion, the variable of chief interest
(Snedecor and Cochran 1967).
For convenience, some of the data are
presented as percentages of control values or
as differences between high-fat and normal
diet, but the statistical evaluations were con-
ducted on the original values.
Results
Body weight and food consumption. Neonatal
parathion exposure had no signiﬁcant effect on
body weight during the immediate treatment
period (PNDs 1–4). However, it affected sub-
sequent growth throughout juvenile, adoles-
cent, and adult stages in a sex-selective manner
(Figure 1A). In males, the low dose of
Early-life parathion exposure
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Figure 1. Effects of neonatal parathion exposure on body weights (A) and food consumption (B) in animals
maintained on a normal diet. Body weight is shown as a percentage of age-matched controls. For refer-
ence, the control weights (grams) for each of the respective ages shown in the graph were males 50.5 ± 0.3,
95.8 ± 0.9, 154 ± 1, 217 ± 2, 276 ± 3, 334 ± 3, 379 ± 4, 412 ± 5, 441 ± 5, 463 ± 5, 493 ± 6, 507 ± 7, 530 ± 7, 540 ± 8,
549 ± 8, 565 ± 9, 574 ± 9, 584 ± 9, 593 ± 10, 601 ± 11; females, 48.6 ± 0.4, 89.1 ± 0.9, 133 ± 1, 170 ± 2, 193 ± 2,
209 ± 3, 232 ± 3, 245 ± 3, 258 ± 4, 268 ± 4, 282 ± 4, 284 ± 5, 293 ± 4, 296 ± 6, 299 ± 6, 306 ± 6, 311 ± 6, 317 ± 6,
314 ± 6, 314 ± 7. For body weights (A), ANOVA shows a significant main effect of parathion treatment
(p < 0.0001) and an interaction of treatment × sex, p < 0.04. In males, the low-dose parathion group is signiﬁ-
cantly different from controls (p < 0.0002 for the main effect of parathion treatment). In females, the low
dose parathion group shows a signiﬁcant increase in body weight (p < 0.05 up to PND80), but starting in the
12th postnatal week, body weights are signiﬁcantly subnormal for both parathion groups (p < 0.0001). For
food consumption (B), ANOVA shows a main effect of parathion (p < 0.0001) and interactions of treatment ×
sex (p < 0.07) and treatment × age (p < 0.07). Males exposed to high-dose parathion show a signiﬁcant treat-
ment effect (p < 0.005) and interaction of treatment × age (p < 0.02). Females show a main effect of treat-
ment (p < 0.0003) with higher food consumption in the low-dose group (p < 0.002). 
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Parathion 0.2parathion elicited a small but highly consistent
and significant increase in body weight
(p < 0.0002 for the main effect of parathion
treatment), whereas at the higher dose, the
weights were not significantly different from
control values but were distinguishable from
the increase seen in the low-dose group
(p < 0.003). The weight differences in females
showed a different profile, with significant
deficits (p < 0.0009 for the main effect of
parathion treatment); the effects generally
intensiﬁed over time, so that although the low
dose of parathion elicited an initial increase in
body weight (up to PND80), starting in the
12th postnatal week, body weights became
clearly subnormal across both parathion groups
(Figure 1A). Because the effects on body
weights could reﬂect underlying differences in
food intake, we assessed consumption in post-
natal weeks 15–22 (Figure 1B). In males, the
low dose of parathion did not affect food con-
sumption but animals exposed to the high dose
showed reduced intake (treatment, p < 0.005;
treatment × age, p < 0.02), primarily during
postnatal weeks 18–20 (PNDs 126–140; treat-
ment, p < 0.0002). Females showed a different
pattern (treatment, p < 0.0003) with higher
food consumption in the 0.1-mg/kg parathion
group (p < 0.002 for the main effect of
parathion treatment) and normal food con-
sumption in the high-dose group.
In control rats, introduction of a high-fat
diet starting on PND105 led to increased
weight gain (Figure 2A) and decreased food
consumption (Figure 2B). In males, high-fat
intake produced a progressive increase in
weight, which by postnatal week 22 reached
about 10% above the values for age-matched
controls consuming a normal diet (p < 0.0001;
Figure 2A). In females, the effect showed a
quicker onset and was much larger, with
almost a 30% increase in body weight by the
end of the study (p < 0.0001). In compensa-
tion for the increased dietary caloric content,
food consumption was reduced in both sexes
(Figure 2B). In males, the reduced food intake
began immediately upon introduction of the
high-fat diet and intensified somewhat with
time (Figure 2B). However, females on the
high-fat diet maintained their food intake ini-
tially and showed a decreased consumption
only after a lag of several weeks (Figure 2B),
likely contributing to their more rapid onset
of extra weight gain.
Early-life exposure to parathion affected
the weight gain imposed by the introduction of
a high-fat diet in adulthood (Figure 3A). In
males, parathion did not alter the additional
weight gain from the high-fat diet; by the end
of the study, all neonatal treatment groups
gained 60 g more than animals on the normal
diet. In females, however, there was a biphasic
effect with increasing parathion dose (treat-
ment, p < 0.0002). Exposure to 0.1 mg/kg/day
of parathion tended to enhance the weight
gain caused by the high-fat diet, whereas expo-
sure to 0.2 mg significantly reduced the
dietary effect (Figure 3A). Food consumption
also showed major sex differences in the effects
of neonatal parathion exposure on the
response to a high-fat diet (Figure 3B). Males
exposed to 0.2 mg/kg/day parathion showed
less of a decrease in food consumption on the
high-fat diet than did controls, with the effect
exhibited primarily during weeks 18–20, mid-
way through the period of dietary manipu-
lation. In contrast, females exposed to
0.2 mg/kg/day parathion showed exactly the
same pattern of decreased food intake as con-
trols when placed on a high-fat diet. We could
not obtain reliable food consumption in the
low-dose females given the high-fat diet
because this group uniquely wasted large
amounts of food, as evidenced by accumula-
tion of debris under the cage. It is not clear if
this is a behavioral difference or simply an
anomaly, but we did observe this behavior in
all but one cage in this group, and the effect
was consistent across all the age points.
Glucose homeostasis. On a normal diet,
neonatal parathion exposure had an effect on
circulating glucose levels, with the higher dose
eliciting a small, but statistically significant
increase (main effect, p < 0.02) that was not
sex-selective (no treatment × sex interaction;
Figure 4A). As expected, fasting reduced glu-
cose levels signiﬁcantly, but this did not elim-
inate the increase caused by neonatal
parathion exposure (no interaction of treat-
ment × feeding status). To illustrate the main
Lassiter et al.
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Figure 2. Effects of switching to a high-fat diet on PND105. (A) Body weight. (B) Food consumption. For
body weight, ANOVA indicates a main effect of diet (p < 0.0001) and interactions of diet × sex (p < 0.0001)
and diet × age (p < 0.03), signiﬁcant for both sexes individually (p < 0.0001 for each). For food consumption
(B), ANOVA indicates a main effect of diet (p < 0.0001) and interactions of diet × sex (p < 0.0005) and diet ×
age (p < 0.0001). For both sexes, there were main effects of diet (p < 0.0001) and interactions of diet × age
(p < 0.0001 for males, p < 0.003 for females).
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100
80
60
40
20
0
110 120 140
E
x
t
r
a
 
w
e
i
g
h
t
 
g
a
i
n
 
(
g
)
C
h
a
n
g
e
 
i
n
 
f
o
o
d
 
c
o
n
s
u
m
p
t
i
o
n
(
g
/
r
a
t
/
d
a
y
)
0
–4
–8
–12
A B
130 150
80
60
40
20
0
Control
Parathion 0.1
Parathion 0.2
0
–4
–8
–12
–16
110 120 130 140 150
Male
Female
Female
Male
PND PNDeffect of parathion, we collapsed the values
across the noninteractive variables (sex, feed-
ing status), calculating the geometric mean of
all values in each treatment group (Figure
4A inset). Introduction of a high-fat diet did
not by itself cause a signiﬁcant change in glu-
cose levels, but it did lessen the hyperglycemic
effect of neonatal parathion exposure to the
point where the parathion effect was no
longer statistically signiﬁcant.
Despite the hyperglycemia caused by
neonatal parathion exposure, we did not ﬁnd
any significant effects of parathion alone on
insulin levels in animals given a normal diet
(Figure 4B); as expected, insulin levels fell in
the fasting state. Introduction of a high-fat diet
evoked a signiﬁcant increase in insulin levels
(p < 0.0001 for the main effect of diet), with a
relatively larger increase in females than in
males (Figure 4B). None of these relationships
showed any statistically signiﬁcant parathion-
related changes.
Since glycation of hemoglobin takes place
over a long time, we assessed HbA1c only in
the fed state. Parathion evoked a significant
reduction in HbA1c (Figure 4C). There was
also a strong sex difference, with males having
higher values than females; although there
was a marginal interaction of treatment × sex
(p < 0.08), the effects were seen in both males
(p < 0.03) and females (p < 0.03), and the
same anomaly was seen after introduction of a
high-fat diet. To illustrate the main effect of
parathion, we collapsed the values across the
noninteractive variables (sex, diet), calculating
the geometric mean of all values in each treat-
ment group (Figure 4C inset).
Lipid homeostasis. Switching to a high-fat
diet produced the expected increases in tri-
glycerides regardless of sex, feeding status, or
neonatal parathion exposure (Figure 5A);
superimposed on the dietary effect, males had
higher values than females, and fasting reduced
the levels. Neonatal parathion exposure altered
the triglyceride pattern in a sex-selective man-
ner that also depended on whether animals
were fed or fasted (Figure 5A). Accordingly,
since feeding status itself had a signiﬁcant effect
on triglycerides, we evaluated effects separated
into fed and fasted values and then identiﬁed
a significant treatment × sex interaction
(p < 0.04) for the fasted state; this reﬂected a
signiﬁcant decrease in females (Figure 5A). To
illustrate the main effect of parathion in fasted
females, we collapsed the values across diet, cal-
culating the geometric mean of all values in
each treatment group (Figure 5A inset).
Cholesterol (Figure 5B) likewise showed
large increases evoked by the high-fat diet,
lower values in males than females, and lower
values in the fasted state. Neonatal parathion
treatment showed interactions with all the
other variables. Given the large effect of feed-
ing status, we again separated the fed from the
fasted values and identified treatment effects
largely conﬁned to the fasted groups and show-
ing sex differences (treatment × sex, p < 0.04).
In males on a normal diet, neonatal parathion
had little or no effect on fasting serum choles-
terol values; however, differences emerged
when animals were switched to a high-fat diet,
with significantly higher cholesterol in the
parathion-exposed males (p < 0.05). On the
other hand, females exposed to neonatal
parathion showed a reduction in fasting choles-
terol (p < 0.05) without clear distinction
between normal and high-fat diets (no treat-
ment × diet interaction). To illustrate the main
effect of parathion in fasted females, we col-
lapsed the values across diet, calculating the
geometric mean of all values in each treatment
group (Figure 5A inset).
By itself, overnight fasting produced sub-
stantial net increases in serum NEFA, and feed-
ing status interacted with diet (p < 0.0002).
Accordingly, we again separated fasting from
fed values for evaluation of parathion effects
(Figure 5C). In the fed state, neonatal
parathion exposure had little or no discernible
effect. In the fasted state, animals on a normal
diet showed a reduction in NEFA caused by
parathion, with significant effects limited to
females. Upon introduction of the high-fat diet,
these differences were no longer evident.
Serum β-hydroxybutyrate showed massive
increases with overnight fasting (Figure 5D), in
keeping with a switch in energy utilization from
glucose to fat. Values were higher in females
and were enhanced by a high-fat diet. The
effects of neonatal parathion treatment inter-
acted with each of the other variables.
Separating the values for fed and fasted animals,
we again observed parathion effects that were
restricted to the fasted state. Males exposed to
parathion showed lower β-hydroxybutyrate val-
ues than fasted controls (p < 0.007), whereas
females did not. The effect did not depend on
whether the animals consumed a normal or
high-fat diet (no interaction of treatment ×
diet). To illustrate the main effect of parathion
in fasted males, we collapsed the values across
diet, calculating the geometric mean of all val-
ues in each treatment group (Figure 5D inset).
Discussion
In our earlier work with chlorpyrifos, we
found that neonatal exposure altered the pro-
gramming of metabolic function, enhancing
hepatic responses to inputs mediating gluco-
neogenesis and lipolysis (Meyer et al. 2004),
with glucose homeostasis maintained only
through increased circulating insulin levels
and attendant hyperlipidemia, essentially pro-
ducing a prediabetic state (Slotkin et al. 2005).
With more prolonged developmental expo-
sures, low doses of chlorpyrifos enhanced adi-
posity and weight gain while dysregulating
leptin, whereas the effect was lost at higher
doses that exceeded the threshold for growth
impairment and other signs of systemic toxic-
ity (Lassiter and Brimijoin 2008). In all these
cases, males showed more prominent effects
than females. Here, in a parallel examination
of the effects of neonatal parathion exposure,
we similarly found a biphasic relationship in
animals maintained on a normal diet. At the
lower dose, below the threshold for signs of
systemic toxicity, the parathion-exposed males
Early-life parathion exposure
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Figure 4. Serum measures related to glucose metabolism in the fed and fasted states in animals exposed to neonatal parathion, followed by normal or high-fat diets
in adulthood. Con, control. (A) Glucose. (B) Insulin. (C) Glycated hemoglobin (HbA1c). For glucose (A), ANOVA indicated a signiﬁcant main effect of parathion for
animals on a normal diet (p < 0.05). Fasting, by itself, decreased glucose levels (p < 0.0001) without altering the treatment effect of parathion (no interaction of treat-
ment × feeding status). The inset shows the values for parathion effects on a normal diet, collapsed across sex and feeding status, and calculated as the geometric
mean of all values. For insulin levels (B), parathion had no signiﬁcant effect, but levels were reduced by fasting (p < 0.0001) and increased by diet (p < 0.0001) in a
sex-selective fashion (diet × sex, p < 0.03). For HbA1c (C) ANOVA indicates a signiﬁcant main effect of parathion (p < 0.002) that was individually signiﬁcant for both
0.1 mg/kg/day (p < 0.02) and 0.2 mg/kg/day groups (p < 0.0005). There was also a main effect of sex (p < 0.0001), but effects were signiﬁcant for both males (p < 0.03)
and females (p < 0.03). The inset shows the values for parathion effects collapsed across sex and diet, and calculated as the geometric mean of all values. 
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Male Female Male Female Male Femaledisplayed essentially an anabolic response,
increasing their weight gain without a corre-
sponding change in food consumption, and
with a reduced mobilization of fat upon fasting,
as evidenced by smaller increase in β-hydroxy-
butyrate compared with the response in con-
trols. When the neonatal parathion dose was
increased to 0.2 mg/kg/day, the subsequent
anabolic response was lost, implying negative
effects on energy metabolism at these higher
exposures. This raises the critical question of
what mechanisms mediate the reversal of the
anabolic actions. One important clue is pro-
vided by the parallel findings of increased
plasma glucose but a reduction in HbA1c.
Ordinarily, HbA1c increases in response to
chronic or repeated episodes of hyperglycemia,
but the fact that we saw a decrease implies that
there is a deficiency in the uptake or utiliza-
tion of glucose by the cell. This recapitulates
one of the functional end points of diabetes,
“starving amid plenty,” albeit by a different
underlying mechanism. Notably, the outcome
after parathion exposure is distinct from that
seen with chlorpyrifos, where plasma glucose
is kept in check by insulin hypersecretion
(Slotkin et al. 2005); the two organophos-
phates produce diabetes-like effects but with
different specific characteristics centered
around circulating insulin, glucose, and lipids.
In contrast to the anabolic effects of low-
level parathion exposure in males, in females,
we found catabolic effects, characterized by
weight deficits, at both doses. This suggests
that females are more sensitive to the negative
metabolic and growth effects of parathion
than males. Indeed, in the low-dose group, the
body weight deficits were superimposed on
increased food consumption, so that they had
a growth deficiency despite higher caloric
intake. Females displayed the same defects in
glucose metabolism as males, with elevated
fasting glucose levels, no compensatory
increase in insulin, and reduced HbA1c point-
ing to deficient cellular uptake/utilization of
glucose. Accordingly, females must have fur-
ther metabolic defects to explain their greater
sensitivity than males, and indeed, these
became evident when we examined serum
markers of lipid metabolism. Parathion-
exposed females displayed decreased levels of
triglycerides, cholesterol, and NEFA, implying
an ongoing reduction in fat utilization, effects
that were not seen in males. Further, with fast-
ing, females exposed to parathion did not
show the reduction in β-hydroxybutyrate pro-
duction that was seen in males, again indicat-
ing an sex difference in the effects on the
ketogenic response to food deprivation.
These ﬁndings all point to more extensive
alterations in lipid metabolism caused by
neonatal parathion exposure in females, associ-
ated with increased susceptibility to metabolic
reprogramming that resulted in a net catabolic
response, as opposed to the biphasic response
seen in males. If this hypothesis is correct, we
would expect to see even greater divergence
between the sexes on a high-fat diet. The high-
fat diet raised serum insulin, triglycerides, cho-
lesterol, NEFA, and β-hydroxybutyrate, all in
keeping with an increase in calories derived
from fat. However, even in controls, there were
significant sex differences in the response to
increased fat intake, with females gaining a rela-
tively greater proportion of body weight.
Regarding parathion effects, in males, the
switch to a high-fat diet revealed further meta-
bolic defects beyond those seen with a normal
diet. Although parathion did not affect the
extra weight gain from high fat, males exposed
to high-dose parathion showed a smaller reduc-
tion in food intake, so they were consuming
more calories in order to grow at the same rate
as the other groups; this implies a worsening of
the catabolic effects compared to those on a
normal diet. The serum markers point to
defects in lipid metabolism as the underlying
cause of the catabolic effects. Whereas only one
parameter of lipid metabolism was affected by
parathion in males on a normal diet (β-hydroxy-
butyrate response to fasting), switching to the
high-fat diet revealed additional abnormalities,
namely an increase in fasting cholesterol and a
greater deficit in the β-hydroxybutyrate
response; the latter potentially connotes an
impaired ability to turn on ketogenesis when
required by food deprivation. Finally, parathion-
exposed males switched to the high-fat diet still
showed a significant reduction in HbA1c
(despite normal circulating glucose levels),
reinforcing that the underlying defect in glucose
uptake/utilization was still present.
Females showed even greater interactions
between neonatal parathion exposure and the
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Figure 5. Serum measures related to lipid metabolism, taken in the fed and fasted states from animals
exposed to neonatal parathion, and given normal or high-fat diets in adulthood. Con, control.
(A) Triglycerides. (B) Cholesterol. (C) Nonesteriﬁed fatty acids. (D) β-Hydroxybutyrate. For triglycerides (A),
ANOVA shows main effects of diet (p < 0.0001), sex (p < 0.0001), and feeding status (p < 0.0001), and an inter-
action for parathion × sex × feeding status (p < 0.08). Lower-order ANOVAs indicate a signiﬁcant treatment
× sex interaction (p < 0.04) in the fasted state, with a signiﬁcant effect limited to females (p < 0.05 for the
main effect of parathion; p < 0.02 for the high-dose parathion group). The inset shows the values for
parathion effects in fasted females collapsed across diet, and calculated as the geometric mean of all val-
ues. For cholesterol (B), ANOVA indicates main effects of diet (p < 0.0001), sex (p < 0.0001) and feeding sta-
tus (p < 0.0001) and interactions of parathion treatment with all three variables: treatment × diet (p < 0.08),
treatment × sex (p < 0.1) and treatment × sex × feeding status (p < 0.1). Lower-order ANOVAs indicate a sig-
niﬁcant effect of parathion in fasted males on the high-fat diet (asterisks). For females, parathion had a sig-
niﬁcant effect on fasting cholesterol (p < 0.05) without dependence on diet; the inset shows the values for
parathion effects in fasted females collapsed across diet, and calculated as the geometric mean of all val-
ues. For NEFA (C), ANOVA indicates a main effect of feeding status (p < 0.0001), an interaction of feeding
status × diet (p < 0.0002) and signiﬁcant effects of parathion treatment on a normal diet (main effect, p <
0.04), limited to females (p < 0.04, asterisks). For β-hydroxybutyrate (D), ANOVA shows main effects of feed-
ing status (p < 0.0001), sex (p < 0.0003), and diet (p < 0.0001), with parathion interactions with all three vari-
ables (p < 0.06 for treatment × feeding status, p < 0.08 for treatment × sex × feeding status, p < 0.09 for
treatment × sex × diet × feeding status). Lower-order ANOVAs indicated signiﬁcant effects in the fasted
state, restricted to males (main effect of parathion, p < 0.007); the inset shows the values for parathion
effects in fasted males collapsed across diet, and calculated as the geometric mean of all values. 
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Low-dose parathion increased the weight gain
caused by elevated fat intake, whereas high-
dose parathion reduced it; the latter effect was
seen even though the animals consumed the
same amount of food (calories), implying fur-
ther induction of a catabolic state. As in the
males, the high-fat diet eliminated the increase
in serum glucose but did not alter the underly-
ing defect in glucose uptake/utilization, as evi-
denced by persistence of a decrease in HbA1c.
In females, the increased fat intake reversed the
deﬁciencies in NEFA but worsened the effects
on triglycerides and cholesterol; the metabolic
mechanisms underlying these interactions
remain to be elucidated, but they do imply
that the parathion-induced alterations of lipid
metabolism contribute to the altered weight
gain caused by the high-fat diet.
Conclusions
Our results point to lasting metabolic dysregu-
lation as a consequence of neonatal parathion
exposure, characterized in males by a net ana-
bolic response at low exposures and a catabolic
response at higher exposures, and in females
by a greater sensitivity to catabolic effects.
Furthermore, there are specific interactions
with dietary fat intake that can worsen the
outcome. The anabolic effects raise the poten-
tial for increased weight gain and potential
exacerbation by a high-fat diet; further, the
metabolic alterations are consistent with a pre-
diabetic state or with end points that are func-
tionally similar to diabetes (elevated glucose,
lipids, reduced ability of the cell to take up or
utilize glucose). Parathion thus shares some,
but not all the characteristics of the metabolic
effects of other organophosphates such as
chlorpyrifos (Lassiter and Brimijoin 2008;
Slotkin et al. 2005) or diazinon (Roegge et al.
2008), reinforcing the fact that although these
agents are all in the same class of pesticides
and all inhibit cholinesterase, they also display
individual effects that are unrelated to that
shared property. Thus, organophosphates are
not all the same in their metabolic effects,
echoing ﬁndings for their individual actions as
developmental neurotoxicants (Jameson et al.
2007; Levin et al. 2001; Pope 1999; Roegge
et al. 2008; Slotkin et al. 2006a, 2006b,
2007a, 2008a; Slotkin and Seidler 2007;
Timofeeva et al. 2008). Although we have not
yet pursued the specific cellular mechanisms
underlying these differences, one likely possi-
bility is divergence in the effects on cell signal-
ing cascades mediating gluconeogenesis and
lipolysis, notably the adenylyl cyclase/cyclic
AMP pathway (Meyer et al. 2004), and stud-
ies are under way to evaluate this possibility.
Our most important findings center on
the tendency to categorize environmental tox-
icants by allocating them to preconceived
classes. Organophosphates are usually
thought of as developmental neurotoxicants,
but they obviously have other important tar-
gets that contribute to morbidity, including
metabolic effects that can have a potential
impact on obesity and diabetes. It is increas-
ingly evident that adverse events in fetal or
neonatal life, including chemical exposures
like those studied here, can lead to mispro-
gramming of metabolism, appetite, and
endocrine status contributing ultimately to
morbidities such as obesity and diabetes
(Breier et al. 2001). Clearly, we need to focus
further research on the speciﬁc contributions
of environmental chemical exposures that
might be contributing to the epidemic of
these and other metabolic disorders.
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